Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Renishaw reports record FY revenues

(Sharecast News) - Engineering company Renishaw reported record full-year revenues on Thursday, with adjusted profits rising despite ongoing macroeconomic pressures and restructuring costs. Renishaw said revenues rose 3.1% to £713.0m in the year ended 30 June, driven by strong demand in semiconductor and defence markets. At constant currency, revenue growth was 3.7%, with notable gains in Asia-Pacific, particularly China.

Adjusted pre-tax profits increased 3.8% to £127.2m, while statutory profits fell 3.7% to £118.0m, reflecting £9.2m in provisions linked to historical tax matters and £4.4m in non-recurring costs, including the closure of its Edinburgh research facility. Adjusted earnings per share rose 3.5% to 137.8p, but statutory EPS dropped 13.5% to 115.2p.

Renishaw, which proposed an increased full-year of 78.1p per share, also said it had made "solid progress" on its innovation-led strategy, with new product launches across metrology, additive manufacturing, and encoder technologies.

The FTSE 250-listed group also confirmed a £20m annualised payroll reduction programme would take effect in the first half of FY26, alongside a £3m benefit from exiting its neurological drug delivery business.

Chief executive Will Lee said: "I am pleased to report record revenue in FY2025, combined with an increase in adjusted profit before tax in what remain challenging market conditions. We continue to make solid progress with our innovation-led growth strategy, introducing many exciting new products this year and equipping our expanded manufacturing facilities for future growth.

"There has been a steady start to FY2026, in line with our expectations. Despite the continued global uncertainty, the structural drivers that underpin our markets are presenting growth opportunities across our businesses and at this stage we are expecting to achieve further steady revenue growth in the year ahead."

As of 0830 BST, Renishaw shares were up 4.98% at 3,353.95p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.